U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Criminal Investigations
  4. Press Releases
  5. Former Spa Owner Pleads Guilty for Using Cosmetic Fillers Not Approved for Distribution in the United States
  1. Press Releases

Former Spa Owner Pleads Guilty for Using Cosmetic Fillers Not Approved for Distribution in the United States

OCI BadgeDepartment of Justice
U.S. Attorney’s Office
Northern District of Oklahoma

FOR IMMEDIATE RELEASE
Friday, April 30, 2021

A woman who operated a Tulsa spa pleaded guilty today in federal court for using medical devices, also known as cosmetic fillers, on patients that were not approved by the U.S. Food and Drug Administration (FDA), announced Acting U.S. Attorney Clint Johnson.

Elisa Kaye Sanders, 61, of Tulsa, pleaded guilty to misdemeanor fraud relating to misbranded devices.

Sanders admitted that on March 10, 2017, she administered the medical devices Juvederm® Ultra 4 and Juvederm® Ultra with Lidocaine to a patient. These specific devices are not approved by the FDA for distribution in the United States and are considered adulterated under the Food, Drug, and Cosmetic Act. Sanders failed to tell the patient she was using unapproved fillers. According to court documents, Sanders purchased the fillers from unauthorized sources and was previously advised by the FDA that purchasing these prescription devices from unauthorized sources was illegal.

Sanders was a majority owner and operator of L’Chaim Medical Spa, previously known as Enhance Skin and Body Medical Spa. The business is no longer in operation.

The Food and Drug Administration, Office of Criminal Investigations conducted the investigation. Assistant U.S. Attorneys Shannon Cozzoni and Scott Proctor are prosecuting the case.

Topic(s):
Prescription Drugs
Component(s):
USAO - Oklahoma, Northern
Contact:
Public Affairs 918-382-2755

Back to Top